382150.KQ
Oncocross Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 3,315.00
−1.34%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.94x
- Price / sales
- 100.82x
- Price / cash flow
- -5.57x
Enterprise value
- Enterprise value
- KRW 15.0B
- EV / sales
- 38.01x
- EV / EBITDA
- -1.44x
- EV / EBIT
- -1.54x
- Market cap
- KRW 39.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026